Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR. Boinapally S, et al. Among authors: brayton c. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4369-4381. doi: 10.1007/s00259-022-05933-3. Epub 2022 Aug 15. Eur J Nucl Med Mol Imaging. 2022. PMID: 35965291
Preclinical Evaluation of 203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer.
Banerjee SR, Minn I, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess AP, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG. Banerjee SR, et al. Among authors: brayton c. J Nucl Med. 2020 Jan;61(1):80-88. doi: 10.2967/jnumed.119.229393. Epub 2019 Jun 28. J Nucl Med. 2020. PMID: 31253744 Free PMC article.
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.
Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG. Banerjee SR, et al. Among authors: brayton c. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2545-2557. doi: 10.1007/s00259-019-04434-0. Epub 2019 Aug 10. Eur J Nucl Med Mol Imaging. 2019. PMID: 31399803 Free PMC article.
Correction to: Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR. Boinapally S, et al. Among authors: brayton c. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4755. doi: 10.1007/s00259-022-05951-1. Eur J Nucl Med Mol Imaging. 2022. PMID: 36044067 No abstract available.
Bone Marrow Relative Biological Effectiveness for a 212Pb-labeled Anti-HER2/neu Antibody.
Liatsou I, Josefsson A, Yu J, Cortez A, Bastiaannet R, Velarde E, Davis K, Brayton C, Wang H, Torgue J, Hobbs RF, Sgouros G. Liatsou I, et al. Among authors: brayton c. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):518-528. doi: 10.1016/j.ijrobp.2022.07.1842. Epub 2022 Aug 1. Int J Radiat Oncol Biol Phys. 2023. PMID: 35926719
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.
Lemberg KM, Zhao L, Wu Y, Veeravalli V, Alt J, Aguilar JMH, Dash RP, Lam J, Tenora L, Rodriguez C, Nedelcovych MT, Brayton C, Majer P, Blakeley JO, Rais R, Slusher BS. Lemberg KM, et al. Among authors: brayton c. Mol Cancer Ther. 2020 Feb;19(2):397-408. doi: 10.1158/1535-7163.MCT-19-0319. Epub 2019 Oct 8. Mol Cancer Ther. 2020. PMID: 31594823 Free PMC article.
105 results